✓ Medically reviewed by · Last reviewed: May 2026
Pharmacy Researcher · 8 years experience
Pharmacy researcher with 8 years reviewing clinical drug information, generic formulation equivalence, and international pharmaceutical standards. Focuses on patient-facing accuracy in medication education.
Key Takeaways
- Rizact is Cipla’s brand of rizatriptan benzoate tablets in 5 mg and 10 mg — a second-generation triptan for acute migraine attacks, with or without aura, in adults.
- Rizatriptan is a selective 5-HT1B/1D receptor agonist. It works by constricting dilated cranial vessels and blocking the release of pain-amplifying neuropeptides (CGRP, substance P) at the trigeminal nerve.
- Onset of headache relief: 30–60 minutes. Rizatriptan 10 mg records the highest 2-hour pain-freedom rate of any oral triptan in network meta-analysis data.
- Critical drug interaction: if you also take propranolol, use Rizact 5 mg only (max 15 mg per day) — propranolol raises rizatriptan plasma levels by ~70%.
- Triptans must not be used on more than 10 days per month. Overuse causes medication-overuse headache — a paradoxical daily headache resistant to further treatment.
- Available to order at MedsBase. No prescription needed. Worldwide Shipping with discreet packaging.
If you’ve been looking at oral triptans and trying to work out which one actually delivers the best result, the clinical evidence points clearly at rizatriptan. In the most comprehensive network meta-analysis of all available triptans (Lancet Neurology, 2019), rizatriptan 10 mg came out on top for 2-hour pain freedom among every oral option tested. Rizact is Cipla’s branded generic of that molecule — same active compound, WHO-GMP manufacturing, and a price that reflects the generic supply chain rather than originator margins.
This guide covers what Rizact is, how triptans work, how to dose correctly (including the propranolol interaction that most patients miss), where Rizact sits relative to other triptans, and the one rule about monthly use frequency that prevents a serious iatrogenic complication.
What Is Rizact?
Rizact is the brand name for rizatriptan benzoate oral tablets manufactured by Cipla Inc — one of the world’s largest WHO-GMP certified pharmaceutical manufacturers. It is available in two strengths: 5 mg and 10 mg.
The drug is indicated for the acute treatment of migraine attacks with or without aura in adults. It is an abortive therapy — taken at the onset of an attack to abort it — not a preventive. It will not reduce the frequency of future migraines.
Cipla also manufactures Rizatop, a sister brand containing rizatriptan 10 mg only. If you need the 5 mg strength (see dosing section), Rizact is the appropriate product. For standard dosing at 10 mg the two are clinically equivalent.
You can see pricing and pack sizes on the Rizact product page, or browse the full range of migraine options in our migraine treatment category.
How Rizatriptan Works — The Triptan Mechanism
Migraine is not simply a headache. It begins with a neurological event — cortical spreading depression — a self-propagating wave of neuronal depolarisation that triggers a cascade ending in pain. As the cascade progresses, meningeal blood vessels dilate, the trigeminal nerve becomes activated, and pro-inflammatory neuropeptides flood the meningeal space. The result: the pulsating, often unilateral headache with nausea, photophobia, and phonophobia that defines a migraine attack.
Rizatriptan interrupts this process at two distinct points:
- Vasoconstriction via 5-HT1B agonism: Cranial blood vessels express 5-HT1B receptors on smooth muscle. Rizatriptan binds them selectively, causing constriction of the dilated meningeal arteries that drive the pulsating quality of migraine pain.
- Neurogenic inflammation block via 5-HT1D agonism: Trigeminal nerve endings also express 5-HT1D receptors. Activation inhibits the release of CGRP (calcitonin gene-related peptide) and substance P — the neuropeptides responsible for the neurogenic inflammation that amplifies and sustains migraine pain.
Because rizatriptan targets the migraine mechanism rather than simply masking pain, it achieves something NSAIDs and paracetamol rarely can: complete pain freedom, not just reduction. In clinical trials, roughly 40–45% of patients who take rizatriptan 10 mg at onset are completely pain-free at 2 hours.
A 2019 Lancet Neurology network meta-analysis of 17 triptans and 68 randomised controlled trials (289,346 attack-treatments) found that rizatriptan 10 mg had the highest 2-hour pain-freedom rate of any oral triptan (RR vs placebo 4.7; 95% CI 3.9–5.6). Eletriptan 40 mg and sumatriptan 100 mg were the nearest comparators. This analysis now directly informs triptan selection guidance in several national headache society guidelines. (Ferrari et al., Lancet Neurol 2019;18:957–70)
Rizact 5 mg vs 10 mg — Which Strength Is Right?
For most adults treating a standard migraine attack, Rizact 10 mg is the evidence-supported first choice. The efficacy advantage of 10 mg over 5 mg is clinically meaningful across all major trial endpoints: 2-hour pain freedom, sustained pain freedom at 24 hours, and rescue-medication use.
Rizact 5 mg is the preferred dose in two specific situations:
1. Propranolol co-prescription
Propranolol is a first-line migraine preventive and a common antihypertensive. It inhibits the CYP450 metabolism involved in rizatriptan clearance, raising rizatriptan plasma AUC by approximately 70%. The interaction is well established and clinically significant: on propranolol, the standard 10 mg Rizact dose effectively becomes a much higher exposure than intended.
Prescribing guidance for both drugs is explicit: maximum single dose of Rizact is 5 mg when co-prescribed with propranolol, with a maximum of 15 mg (three 5 mg doses) in any 24-hour period. If you use Inderal (propranolol) for migraine prevention or cardiovascular disease, you need Rizact 5 mg — not 10 mg.
2. Tolerability
The chest tightness, paresthesia, and flushing that some patients experience on triptans are dose-related. Patients who find 10 mg produces noticeable chest heaviness may achieve adequate headache relief with 5 mg and a more acceptable side-effect burden.
Rizact Dosing Protocol
When to take it: At the very first sign of migraine pain or aura. The pharmacological window for triptans closes as the attack progresses. Once central sensitisation is established — usually signalled by allodynia (the scalp or skin becoming painful to light touch) — triptans lose most of their ability to achieve pain freedom. Earlier is reliably better.
- Standard dose: 10 mg (or 5 mg if on propranolol or for tolerability reasons)
- With or without food: Both are fine, but food delays absorption by approximately 1 hour. For maximum speed, take on an empty stomach.
- Repeat dose: If the headache resolves then recurs (migraine recurrence occurs in ~25–30% of responders), a second dose may be taken no sooner than 2 hours after the first.
- Maximum per 24 hours: 30 mg total (three 10 mg doses). Most guidelines recommend a practical ceiling of 20 mg (two doses) to preserve the safety margin.
- Maximum per month: 10 days — see the medication-overuse headache section below.
What if Rizact doesn’t work? If a full 10 mg dose taken early in the attack fails to produce any response, consider switching to a different triptan class or route on the next attack. Non-response to rizatriptan occurs in around 30–35% of users; there is good evidence that ~50% of non-responders to one triptan will respond to another. Nasal-route triptans such as Zolmist (zolmitriptan 5 mg nasal spray) bypass gut absorption entirely and may work where oral tablets have failed.
Side Effects and Contraindications
Triptans are among the best-tolerated acute migraine treatments, but their vasoconstrictive mechanism creates a specific contraindication profile that is non-negotiable:
- Known or suspected coronary artery disease, previous heart attack, or peripheral vascular disease
- Uncontrolled hypertension
- Prinzmetal angina (vasospastic angina)
- Hemiplegic or basilar-type migraine (triptans may worsen these neurological variants)
- Used an ergot-containing drug (ergotamine, dihydroergotamine) in the previous 24 hours
- Used a monoamine oxidase inhibitor (MAOI) in the previous 14 days
- Used another triptan in the previous 24 hours
- Severe hepatic impairment
Common side effects in clinical trials (occurring in 5% or more of users):
- Dizziness and somnolence
- Fatigue or weakness (asthenia)
- Nausea
- Chest, throat, or jaw tightness — usually transient and non-cardiac in origin, but discontinue if significant
- Paresthesia (pins and needles, typically in the extremities)
- Dry mouth
These effects are typically mild, transient, and resolve without intervention within 1–2 hours. They are rarely a reason to stop treatment permanently, but if chest tightness is pronounced, switching to a 5 mg dose or a different triptan on subsequent attacks is a reasonable step.
Rizact vs Other Triptans — Comparison Table
Understanding where each triptan fits clinically helps you choose the right tool for the attack in front of you. The options available through MedsBase cover the three most clinically significant positions:
| Drug (Brand) | Dose / Route | Onset | 2h Pain Freedom | Best Use Case |
|---|---|---|---|---|
| Rizact (rizatriptan) | 5 / 10 mg oral | 30–60 min | ~40–45% | Standard first-choice oral triptan; highest 2h efficacy data |
| Rizatop (rizatriptan 10 mg) | 10 mg oral | 30–60 min | ~40–45% | Same molecule; 10 mg only — choose Rizact if 5 mg strength needed |
| Suminat (sumatriptan) | 50–100 mg oral | 45–90 min | ~28–32% | Longest clinical track record; well tolerated; widely used first-line |
| Zolmist (zolmitriptan nasal) | 5 mg nasal spray | 10–15 min | ~35–38% | Migraine with severe nausea/vomiting; fastest overall onset; bypasses gut |
Clinical summary: For a standard migraine attack where swallowing a tablet is practical, Rizact 10 mg is the evidence-best oral option. For attacks with severe nausea, vomiting, or gastric stasis — which slows oral drug absorption — Zolmist nasal spray delivers drug systemically within 10–15 minutes, bypassing the gut entirely. The Best Migraine Medications 2026 guide covers additional options including preventives and newer CGRP pathway agents.
Medication-Overuse Headache — The 10-Day Rule
This section matters more than most patients realise when they first start using acute migraine medication.
Medication-overuse headache (MOH) — also called rebound headache or analgesic rebound — develops when any acute headache drug is used on more than 10 days per month for three or more consecutive months. The result is a paradoxical transformation: the very drugs used to relieve migraine cause a chronic daily or near-daily background headache that becomes increasingly resistant to treatment.
MOH affects an estimated 1–2% of the general population and represents one of the most common causes of chronic daily headache in headache clinic populations. The tragedy is that it is almost entirely preventable by following one rule:
Use triptans on no more than 10 days per calendar month. If your migraine frequency already requires acute treatment more than 10 days per month, this is a clear signal that you need a preventive therapy — adding more acute medication use will not solve the problem and will worsen it over time.
A headache diary tracking attack dates, duration, severity, and drugs used is the most practical self-monitoring tool. Three consecutive months of entries will reveal any creeping overuse pattern before it becomes entrenched MOH.
When to Add a Preventive Migraine Treatment
Preventive therapy is indicated when:
- Migraine occurs on 4 or more days per month
- Attacks are prolonged (≥12 hours) or severely disabling regardless of frequency
- Acute therapy is needed more than 10 days per month (MOH risk threshold)
- Acute therapy is contraindicated or poorly tolerated
The goal of prevention is a ≥50% reduction in monthly attack frequency. Well-evidenced first-line preventives available on MedsBase include:
- Inderal (propranolol) — beta-blocker; one of the longest-established evidence-based migraine preventives. Typical dose: 40–160 mg daily in divided doses. Note the Rizact 5 mg dose adjustment when co-prescribing.
- Cotrip (amitriptyline) — tricyclic antidepressant used at sub-antidepressant doses for migraine prevention, particularly when attacks co-occur with poor sleep, tension-type headache, or depression. Start 10 mg nightly, titrate to 25–75 mg. Allow 8–12 weeks for full effect.
Prevention is not a decision to take lightly — all preventives carry their own side-effect profiles and require consistent daily adherence. But for patients whose migraines are frequent or disabling, the benefit-risk balance favours prevention over escalating acute medication use.
Frequently Asked Questions About Rizact
How quickly does Rizact work?
Most patients notice meaningful headache relief within 30–60 minutes of taking Rizact 10 mg. The median time to headache response (pain reduced from moderate or severe to mild or none) in controlled trials is approximately 45 minutes. Full pain freedom at 2 hours is achieved in approximately 40–45% of patients. For faster onset, the nasal-spray route (Zolmist) reduces time-to-onset to 10–15 minutes.
Can I take Rizact on an empty stomach?
Yes, and this is often advisable. Food delays rizatriptan absorption by approximately 1 hour without changing the total amount absorbed. For fastest onset — particularly important when taking Rizact at the very first sign of an attack — take it before eating.
Is Rizact a branded generic? How is it different from the originator?
Rizact is Cipla’s branded generic of rizatriptan benzoate. The active molecule is chemically identical to Maxalt, the originator brand. Cipla manufactures Rizact under WHO-GMP certification and to bioequivalence standards (same Cmax, AUC, and Tmax as the reference product). The clinical effect is equivalent; the price reflects the generic supply chain.
What is the difference between Rizact and Rizatop?
Both are Cipla rizatriptan tablets. Rizatop is available in 10 mg only. Rizact is available in both 5 mg and 10 mg. The 5 mg option matters primarily for patients co-prescribed propranolol. For standard 10 mg dosing, both products are clinically equivalent.
Why doesn’t Rizact work sometimes?
Three main reasons: (1) Late dosing — rizatriptan is most effective before central sensitisation is established. If you wait until pain is already severe, pain-freedom rates drop by 15–20%. (2) Allodynia — once the scalp or skin hurts to light touch (cutaneous allodynia), central sensitisation is established and triptans rarely achieve full pain freedom. (3) Medication overuse — if you’re using triptans more than 10 days per month, MOH chronification reduces the efficacy of all acute therapies.
Can rizatriptan cause rebound headache?
Yes — this is the medication-overuse headache (MOH) risk described in detail above. Triptans have a slightly lower MOH risk threshold than simple analgesics (10 days/month for triptans vs 15 days/month for NSAIDs), but the risk is real and well documented. Staying below 10 treatment days per month is the complete prevention strategy.
Where can I order Rizact online?
Rizact is available to order at MedsBase via the Rizact product page. No prescription is required. Orders are dispatched in discreet packaging via Worldwide Shipping. For the full range of migraine treatments, visit the migraine treatment category.
Written by
Sophie ChenPharmaceutical Content Researcher · 8 years experience
Sophie Chen is a pharmaceutical content researcher with 8 years covering generic medication access and clinical pharmacology. She specialises in international regulatory frameworks, bioequivalence standards, and patient-facing education on therapeutic drug classes. She is not a clinician.